Struers.ch

MATERIAL SAFETY DATA
IDENTIFICATION OF THE SUBSTANCE/PREPARATION AND OF THE COMPANY/UNDERTAKING
For embedding of materialographic specimens Container size: Responsible for safety data sheet authoring: HAZARDS IDENTIFICATION
May cause sensitisation by skin contact. Contains a substance which may be potentially carcinogenic. The hazardous properties of the product in the environment are considered to be limited.
COMPOSITION/INFORMATION ON INGREDIENTS
The product contains: plasticiser and fillers.
FIRST-AID MEASURES
Move injured person into fresh air and keep person calm under observation. If uncomfortable: Seek hospital and bring these instructions.
Remove contaminated clothing immediately and wash skin with soap and water. In case of eczema or other skin disorders: Seek medical attention and bring these instructions.
Immediately flush with plenty of water for up to 15 minutes. Remove any contact lenses and open eyelids widely. If irritation persists: Continue flushing during transport to hospital. Bring along these instructions.
Immediately rinse mouth and drink plenty of water. Keep person under observation. If person becomes uncomfortable seek hospital and bring these instructions. Do not induce vomiting.
MATERIAL SAFETY DATA SHEET
FIRE-FIGHTING MEASURES
Use fire-extinguishing media appropriate for surrounding materials.
Selection of respiratory protection for fire fighting: follow the general fire precautions ACCIDENTAL RELEASE MEASURES
Avoid inhalation of dust and contact with skin and eyes. For personal protection, see section 8.
Avoid discharge into drains, water courses or onto the ground.
Dampen spillage with water. Absorb spillage with suitable absorbent material. Look out! The product is hazardous to your health. For waste disposal, see section 13.
HANDLING AND STORAGE
Avoid spread of dust. Avoid inhalation of dust and contact with skin and eyes. Observe good chemical hygiene practices.
Work practice should minimize contact.
Store in tightly closed original container. Store under well-ventilated conditions at a temperature below 25°C.
MATERIAL SAFETY DATA SHEET
EXPOSURE CONTROLS/PERSONAL PROTECTION
Provide adequate ventilation. Observe Occupational Exposure Limits and minimize the risk of inhalation of dust. An eye wash bottle must be available at the work site. Local exhaust is recommended.
Personal protection equipment should be chosen according to the the CEN standards and in collaboration with the supplier of the personal protective equipment.
During dust-raising work: Use respiratory equipment with particle filter, type P2.
Goggles/face shield are recommended.
Environmental Exposure Not available. (*)Controls: PHYSICAL AND CHEMICAL PROPERTIES
10. STABILITY AND REACTIVITY
Stable under normal temperature conditions.
When heated, toxic and corrosive vapours/gases may be formed.
MATERIAL SAFETY DATA SHEET
11. TOXICOLOGICAL INFORMATION
Dust may irritate throat and respiratory system and cause coughing.
Prolonged contact may cause redness and irritation.
Dust in the eyes will cause irritation.
Risk of sensitization or allergic reactions among sensitive individuals. Contains a substance which may be potentially carcinogenic. Carcinogenicity: National Toxicology Program (NTP): Yes I.A.R.C. Monographs: Yes OSHA: Yes 12. ECOLOGICAL INFORMATION
The product is insoluble in water and will sediment in water systems.
The environmental hazard of the product is considered to be limited.
No data available on bioaccumulation.
13. DISPOSAL CONSIDERATIONS
Dispose of waste and residues in accordance with local authority requirements. Waste is classified as hazardous waste.
14. TRANSPORT INFORMATION
The product is not covered by international regulation on the transport of dangerous goods (IMDG, IATA, ADR/RID).
MATERIAL SAFETY DATA SHEET
15. REGULATORY INFORMATION
May cause sensitisation by skin contact.
This material and its container must be disposed of as hazardous waste.
NFPA Rating: Health:2 Fire:0 Reactivity:0 Other:- TSCA: Listed. As a general rule, persons under 18 years of age are not allowed to work with this product.
Europe/USA:This Safety Data Sheet has been prepared according to the EU-regulation.
Threshold Limit Values (2008), ACGIH, by the American Conference on Governmental Industrial Hygienists.
The Code of Federal Regulation, Title 29, part 1910. Occupational Safety and Health Standards, Air contaminants (OSHA), with amendments.
MATERIAL SAFETY DATA SHEET
16. OTHER INFORMATION
The user must be instructed in the proper work procedure and be familiar with the contents of these instructions. The following sections contain revisions or new statements: 8. The (*) indicates the changes made with respect to the previous version.
Risk of explosion by shock, friction, fire or other sources of ignition.
May cause sensitisation by skin contact.
The information on this data sheet represents our current data and is reliable provided that the product is used under the prescribed conditions and in accordance with the application specified on the packaging and/or in the technical guidance literature. Any other use of the product which involves using the product in combination with any other product or any other process is the responsibility of the user.
Made by DHI - Centre for Environment and Toxicology, Agern Allé 5, DK-2970 Hørsholm, Denmark.

Source: http://www.struers.ch/resources/elements/12/106921/TRIOFIX-2%20POWDER%20(M1201060%20-%202008-05-08).pdf

Septoplasty and/or endoscopic sinus surgery post-operative instructions

TIER ENT ASSOCIATES, P.C. 15 Riverside Drive Johnson City, NY 13790 607-770-9050 Septoplasty and/or Endoscopic Sinus Surgery post-operative instructions Items typically needed: Medications: Unless otherwise stated, antibiotics should begin the day after surgery if no significant nausea or vomiting have occurred. Prescription pain medicine is almost always needed and should be

Microsoft word - van den broek-benjamin-scriptie

URGENTIES IN DE PALLIATIEVE THUISZORG HAIO: Benjamin Van den Broek PROMOTOR: Professor Dr. Paul Clement Samenvatting Achtergrond: Een gemiddelde huisartsenpraktijk in België telt zo’n 3 à 4 palliatieve patiënten per jaar. (1) Onderzoek toont aan dat zowat 70% van deze mensen verkiezen om thuis te sterven. Als huisarts draagt men dus een grote verantwoordelijkheid om tegemo

Copyright © 2013-2018 Pharmacy Abstracts